Structural Digital Database Compliance Certificate for year ended March 31, 2025
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has submitted a compliance certificate to NSE confirming that it maintained a Structured Digital Database (SDD) for tracking Unpublished Price Sensitive Information (UPSI) during FY 2024-25, as required by SEBI's Insider Trading Regulations. The certificate, issued by Practising Company Secretary Mr. Dinesh Bhandari, confirms the database is in place, has controlled access, is non-tamperable, retains records for 8 years, and has an audit trail. The company was required to capture 5 events during the year (related to financial results, preferential issue, bonus issue, migration to main board, and change in KMP) and all 5 were successfully recorded.
This is a routine regulatory compliance filing and is neutral for shareholders. It confirms the company has proper systems in place to track insider information and prevent insider trading, which is a basic governance requirement for listed companies.